Table 3.
Parameter | Regression coefficient (95% CI)a | p |
---|---|---|
Total sweat volume by QSART and total UENS score | ||
Variable | ||
UENS score | 0.79 (0.68–0.92) | 0.003 |
Age (unit=1 year) | 0.98 (0.86–1.12) | 0.81 |
CD4+ T cells (unit = 100 cells/mm3) | 1.00 (0.99–1.00) | 0.08 |
Sex | 0.61 (0.06–5.96) | 0.66 |
Current or prior d-drug NRTI use | 0.33 (0.03–3.72) | 0.36 |
Total sweat volume by QSART and worst pain over past week by VAS | ||
Variable | ||
Worst pain over past week | 0.96 (0.91–1.02) | 0.20 |
Age (unit=1 year) | 0.98 (0.84–1.13) | 0.79 |
CD4+ T cells (unit = 100 cells/mm3) | 1.00 (0.99–1.00) | 0.08 |
Sex | 0.84 (0.05–12.89) | 0.90 |
Current or prior d-drug NRTI use | 0.34 (0.02–5.18) | 0.42 |
Total UENS score and worst pain over past week by VAS | ||
Variable | ||
Worst pain over last week | 1.25 (1.17–1.34) | <0.001 |
Age (unit=1 year) | 1.03 (0.87–1.23) | 0.66 |
CD4+ T cells (unit = 100 cells/mm3) | 0.99 (0.99–1.00) | 0.62 |
Sex | 0.10 (0.00–2.46) | 0.15 |
Current or prior d-drug NRTI use | 0.46 (0.01–11.07) | 0.62 |
Data are exponential of regression coefficients (95% confidence interval), which indicates fold change in the outcome variable of interest by one interquartile increase in the corresponding covariate.
CI=confidence interval, QSART=quantitative sudomotor axon reflex test, UENS=Utah Early Neuropathy Scale, VAS=visual analog scale, NRTI=nucleoside reverse transcriptase inhibitor